Infectious Disease

Internal Medicine

Questions discussed in this category

Do you recommend procalcitonin to help convince other providers to stop antibiotics in patients with pneumonia in whom a non-infectious diagnosis is strongly suspected?

3 Answers available

Do you recommend routine neurosyphilis testing in patients being evaluated for dementia?

2 Answers available

Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?

2 Answers available

How do you use gut microbiome or gut microbiota analysis in your clinical practice, if at all?

5 Answers available

What is your preferred dosing of IV ganciclovir for CMV disease in immunocompromised patients?

1 Answer available

Papers discussed in this category

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022 Sep 10

Use of biomarkers to individualize antimicrobial therapy duration: a narrative review.

The Lancet. Infectious diseases, 2016 Mar 02

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Experimental cell research, 1985 Jan

Cell growth, cell division and cell size homeostasis in Swiss 3T3 cells.

JAMA, 2024 Dec 09

Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.

Dig Dis Sci, 2020 Sep

Mapping the Segmental Microbiomes in the Human Small Bowel in Comparison with Stool: A REIMAGINE Study.

Related Topics in Infectious Disease